Laponis Adam 4

What Happened

• Adam Laponis, Chief Financial Officer of Twist Bioscience (TWST), sold 2,399 shares on July 9, 2026 at $94.33 per share, generating $226,307. The sale was a "sell-to-cover" tied to the vesting of restricted stock units (RSUs) and was used to satisfy tax-withholding obligations rather than a discretionary sale.

Key Details

• Transaction date: 2026-07-09; Price: $94.33 per share; Total proceeds: $226,307.
• Transaction type: Sale (S) — reported as open market or private sale but described in the footnote as a mandated sell-to-cover for taxes.
• Shares owned after transaction: Not disclosed in the filing excerpt.
• Filing: Report filed 2026-07-13 (covers period of report 2026-07-09); filing appears timely (filed within required business-day window).
• Footnote: Sale was required to cover tax withholding on vested RSUs and was not a discretionary trade by the reporting person.

Context

• Sell-to-cover transactions are common when RSUs vest: the company (or broker) sells a portion of the vested shares to pay required payroll/tax withholding. Such sales typically reflect tax mechanics, not an insider's view on the stock.